Ranjan Singh
January 12, 2026
The COVID-19 pandemic revealed a vast inequity in Africa’s access to vaccines. Africa had to import 99% of its COVID-19 vaccines and of the 3 billion doses administered globally just 2% went to African countries. This has prompted a push to boost Africa’s homegrown vaccine manufacturing capacity.
Bringing you weekly curated insights and analysis on the global issues that matter.
Ranjan Singh
January 12, 2026